Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.260
+0.050 (2.26%)
At close: Jun 12, 2026, 4:00 PM EDT
2.230
-0.030 (-1.33%)
Pre-market: Jun 15, 2026, 7:48 AM EDT

Alaunos Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.351.391.096.0639.0676.05
Cash & Short-Term Investments
0.351.391.096.0639.0676.05
Cash Growth
10.97%26.95%-82.00%-84.48%-48.64%-33.91%
Accounts Receivable
-00.0100-
Other Current Assets
0.620.61.662.214.742.78
Total Current Assets
0.971.992.768.2653.878.83
Net Property, Plant & Equipment
0.080.09-010.615.36
Other Long-Term Assets
0.830.89--0.540.67
Total Assets
1.882.972.768.2664.9494.87
Accounts Payable
0.40.610.520.621.391.37
Accrued Expenses
0.20.20.181.345.456.08
Current Portion of Long-Term Debt
----16.777.87
Current Portion of Leases
----0.560.73
Total Current Liabilities
0.60.810.691.9624.1716.04
Long-Term Debt
-----16.25
Long-Term Leases
----2.194.52
Other Long-Term Liabilities
----0.03-
Total Long-Term Liabilities
----2.2220.77
Total Liabilities
0.60.810.691.9626.3836.81
Common Stock
00000.020.22
Additional Paid-in Capital
926.91926.77922.51922.07919.17900.69
Retained Earnings
-925.63-924.62-920.45-915.77-880.63-842.85
Shareholders' Equity
1.292.152.066.3138.5658.06
Total Liabilities & Equity
1.882.972.768.2664.9494.87
Total Debt
-00019.5129.37
Net Cash (Debt)
0.351.391.096.0619.5546.69
Net Cash Growth
-74.44%26.95%-82.00%-68.99%-58.13%-57.65%
Net Cash Per Share
0.170.710.683.7913.5032.66
Book Value
1.292.152.066.3138.5658.06
Book Value Per Share
0.631.111.293.9426.6340.62
Tangible Book Value
1.292.152.066.3138.5658.06
Tangible Book Value Per Share
0.631.111.293.9426.6340.62
SEC Filings: 10-K · 10-Q